{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:28:10Z","timestamp":1792686490459,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.tox.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T07:20:41Z","timestamp":1475911241000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"special_numbering":"C","title":["An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures"],"prefix":"10.1016","volume":"371","author":[{"given":"George J.","family":"Dugbartey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J.","family":"Peppone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge A.M.","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.10.001_bib0005","first-page":"121","article-title":"Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatininduced nephrotoxicity in rat","volume":"5","author":"Ahangarpour","year":"2014","journal-title":"Vet Res Forum"},{"key":"10.1016\/j.tox.2016.10.001_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/SHK.0000000000000478","article-title":"AP39, A mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo","volume":"45","author":"Ahmad","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.tox.2016.10.001_bib0015","first-page":"129","article-title":"Update on the diagnosis and management of acute kidney injury","volume":"3","author":"Akcay","year":"2010","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.tox.2016.10.001_bib0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.phrs.2005.12.005","article-title":"Propionyl-l-carnitine prevents the progression of cisplatin-induced cardiotoxicity in a carnitine-depleted rat model","volume":"53","author":"Al-Majed","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0025","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1016\/j.fct.2008.07.030","article-title":"Ontogenic aspects of cisplatin-induced nephrotoxicity in rats","volume":"46","author":"Ali","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2016.10.001_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4236\/jbbs.2012.21011","article-title":"Cisplatin-induced posterior reversible encephalopathy syndrome \u2013 a brief report and review of the literature","volume":"2","author":"Amit","year":"2012","journal-title":"J. Behav. Brain Sci."},{"key":"10.1016\/j.tox.2016.10.001_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbi.2016.03.036","article-title":"Hydrogen sulfide modulates sub-cellular susceptibility to oxidative stress induced by myocardial ischemic reperfusion injury","volume":"252","author":"Ansari","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2016.10.001_bib0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/phrs.1999.0600","article-title":"Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study","volume":"41","author":"Antunes","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/phrs.2000.0724","article-title":"Effects of the antioxidant curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats","volume":"43","author":"Antunes","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0050","first-page":"80","article-title":"Adverse cardiac manifestations of cisplatin- a review","volume":"18","author":"Bano","year":"2013","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tox.2016.10.001_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.cdd.4401817","article-title":"Cellular response to endoplasmic reticulum stress: a matter of life or death","volume":"13","author":"Boyce","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tox.2016.10.001_bib0065","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0070","first-page":"72","article-title":"Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects","volume":"26","author":"Capizzi","year":"1999","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0075","first-page":"85","article-title":"Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine","volume":"85","author":"Castiglione","year":"1999","journal-title":"Tumori"},{"key":"10.1016\/j.tox.2016.10.001_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0003-9861(02)00342-9","article-title":"L-carnitine inhibits cisplatin- induced injury of the kidney and small intestine","volume":"405","author":"Chang","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tox.2016.10.001_bib0085","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/01635580802100869","article-title":"Diallyl disulfide prevention of cis-diamminedichloroplatinum-induced nephrotoxicity and leukopenia in rats: potential adjuvant effects","volume":"60","author":"Chiarandini Fiore","year":"2008","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tox.2007.12.007","article-title":"Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity","volume":"245","author":"Chirino","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.10.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1002\/biof.1301","article-title":"Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endosplasmic reticulum stress responses","author":"Chowdhury","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.tox.2016.10.001_bib0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via human organ cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.10.001_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.1993.1184","article-title":"Nephrotoxicity and hydration management for cisplatin, carboplatin and ormaplatin","volume":"50","author":"Cornelison","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10863-006-9059-5","article-title":"Mitochondria as a critical target of the therapeutic agent cisplatin in head and neck cancer","volume":"39","author":"Cullen","year":"2007","journal-title":"J. Bioenergy Biomembr."},{"key":"10.1016\/j.tox.2016.10.001_bib0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.1988.132","article-title":"Renal tubular function in patients treated with high-dose cisplatin","volume":"44","author":"Daugaard","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.10.001_bib0120","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.V12122683","article-title":"Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide","volume":"12","author":"Davis","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2016.10.001_bib0125","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2001.19.17.3733","article-title":"Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure","volume":"19","author":"de Jongh","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0130","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"de Jongh","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.tox.2016.10.001_bib0135","first-page":"6","article-title":"The cardiac markers and oxidative stress parameters in advanced non-small cell lung cancer patients receiving cisplatin-based chemotherapy","volume":"22","author":"Demkow","year":"2011","journal-title":"eJIFCC"},{"key":"10.1016\/j.tox.2016.10.001_bib0140","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1046\/j.1523-1755.2001.00043.x","article-title":"Interleuikin-10 inhibits ischemic and cisplatin-acute renal injury","volume":"60","author":"Deng","year":"2001","journal-title":"Kid. Int."},{"key":"10.1016\/j.tox.2016.10.001_bib0145","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","article-title":"Biochemical markers for prediction of chemotherapy-based cardiotoxicity: systematic review of the literature and recommendations for use","volume":"130","author":"Dolci","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.tox.2016.10.001_bib0150","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1523\/JNEUROSCI.0523-07.2007","article-title":"Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy","volume":"27","author":"Dzagnidze","year":"2007","journal-title":"J. Nuerosci."},{"key":"10.1016\/j.tox.2016.10.001_bib0155","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.072067999","article-title":"Curing metastatic testicular cancer","volume":"99","author":"Einhorn","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tox.2016.10.001_bib0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejphar.2010.09.085","article-title":"Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies","volume":"650","author":"El-Awady","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2016.10.001_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbi.2013.11.008","article-title":"Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats","volume":"207","author":"El-Sawalhi","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2016.10.001_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5455\/jppa.20130215073523","article-title":"Effects of hydrogen sulfide on oxidative stress, tnf-\u03b1 level and kidney histological changes in cisplatin nephrotoxicity in rat","volume":"3","author":"Fard","year":"2013","journal-title":"J. Phys. Pharm. Adv."},{"key":"10.1016\/j.tox.2016.10.001_bib0175","first-page":"459","article-title":"Effects of exogenous and endogenous hydrogen sulfide on plasma renin and erythropoietin in cisplatin-induced nephrotoxicity in rats","volume":"26","author":"Fard","year":"2015","journal-title":"URMIAMJ"},{"key":"10.1016\/j.tox.2016.10.001_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0960327106072389","article-title":"Vitamin C attenuates cisplatin-induced alterations in renal brush border membrane enzymes and phosphate transport","volume":"26","author":"Fatima","year":"2007","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2016.10.001_bib0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.107.119792","article-title":"Cisplatin-induced acute renal failure is associate with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney","volume":"322","author":"Faubel","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.10.001_bib0190","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/1078-0432.CCR-10-0949","article-title":"Influence of Oct1\/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-{beta}-d-glucosaminidase","volume":"16","author":"Franke","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0195","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.29.1_supplement.938.6","article-title":"Urinary KIM-1 is a novel biomarker for cisplatin-induced subclinical nephrotoxicity in oncology patients","volume":"29","author":"George","year":"2015","journal-title":"FASEB"},{"key":"10.1016\/j.tox.2016.10.001_bib0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/gyno.1996.0090","article-title":"The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer","volume":"61","author":"Gogas","year":"1996","journal-title":"Gyenecol. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0024-3205(83)90299-0","article-title":"Minireview: the nephrotoxicity of cisplatin","volume":"32","author":"Goldstein","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2016.10.001_bib0210","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpo.10335","article-title":"Cisplatin nephrotoxicity affects magnesium and calcium metabolism","volume":"41","author":"Goren","year":"2003","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0215","first-page":"191","article-title":"Acute and long-term nephrotoxicity of cis- platinum in man","volume":"17","author":"Groth","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.10.001_bib0220","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.ajpath.2011.02.020","article-title":"Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy","volume":"178","author":"Grube","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.10.001_bib0225","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/europace\/eup300","article-title":"Introducing a new entity: chemotherapy-induced arrhythmia","volume":"11","author":"Guglin","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.tox.2016.10.001_bib0230","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/44.10.8813074","article-title":"Immunohistochemical detection of \u03b3-glutamyl transpeptidase in normal human tissue","volume":"44","author":"Hanigan","year":"1996","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tox.2016.10.001_bib0235","first-page":"5925","article-title":"Inhibition of \u03b3-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity","volume":"54","author":"Hanigan","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0240","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1158\/1078-0432.CCR-06-2289","article-title":"Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity","volume":"14","author":"Harned","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0245","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.tox.2016.10.001_bib0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","article-title":"American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants","volume":"27","author":"Hensley","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0255","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/sj.onc.1209440","article-title":"Regulation of PUMA- alpha by p53 in cisplatin-induced renal cell apoptosis","volume":"25","author":"Jiang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2016.10.001_bib0260","doi-asserted-by":"crossref","first-page":"F983","DOI":"10.1152\/ajprenal.90579.2008","article-title":"Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway","author":"Jiang","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1191\/0960327104ht413oa","article-title":"The effects of desferrioxamine on cisplatin-induced lip peroxidation and the activities of antioxidant enzymes in rat kidneys","volume":"23","author":"Kadikoylu","year":"2004","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2016.10.001_bib0270","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","article-title":"Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis","volume":"49","author":"Kalam","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2006.03.016","article-title":"Cardioprotective effects of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats","volume":"115","author":"Karthikeyan","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cvsm.2012.01.003","article-title":"Toxicology of frequently endcountered nonsteroid anti- inflammatory drugs in dogs and cats","volume":"42","author":"Khan","year":"2012","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.tox.2016.10.001_bib0285","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1200\/JCO.2011.38.7852","article-title":"Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma","volume":"30","author":"Khan","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0290","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1158\/0008-5472.CAN-08-1365","article-title":"Combination therapy with cisplatin and anti-4-1BB: synergistic anticancer effects and amelioration of cisplatin- induced nephrotoxicity","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2010.04.003","article-title":"Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs","volume":"11","author":"Kim","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.tox.2016.10.001_bib0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfu096","article-title":"Identification of noninvasive biomarkers of nephrotoxicity using HK-2 human kidney epithelial cells","volume":"140","author":"Kim","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.10.001_bib0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jphs.2014.11.009","article-title":"Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation","volume":"127","author":"Kim","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.tox.2016.10.001_bib0310","first-page":"1","article-title":"Acute toxicologic and pathologic effects of cis- diamminedichloroplatinum (NSC-119875) in the male rat","volume":"55","author":"Kociba","year":"1971","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.tox.2016.10.001_bib0315","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/01913120290104683","article-title":"Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findings","volume":"26","author":"Kohn","year":"2002","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.tox.2016.10.001_bib0320","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00280-002-0537-0","article-title":"Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl-l-cysteine-cDDP by TEA and PAH in the renal proximal tubule","volume":"51","author":"Kolb","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2016.10.001_bib0325","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3565(24)36493-6","article-title":"Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain","volume":"280","author":"Kruidering","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.10.001_bib0330","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00280-005-1010-7","article-title":"Magnesium depletion enhances cisplatin-induced nephrotoxicity","volume":"56","author":"Lajer","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2016.10.001_bib0335","first-page":"1013","article-title":"Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells","volume":"62","author":"Lee","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2016.10.001_bib0340","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1681\/ASN.2004090768","article-title":"Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis","volume":"16","author":"Liu","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2016.10.001_bib0345","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.1998.16.7.2500","article-title":"Vinblastine plus ifosphamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor","volume":"16","author":"Loehrer","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0350","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.toxrep.2015.01.017","article-title":"Biochemical changes associated with ascorbic acid-cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice","volume":"2","author":"Longchar","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.tox.2016.10.001_bib0355","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000421-199010000-00007","article-title":"Phase I study of acivicin and cisplatin in non-cell lung cancer: a national cancer institute of Canada study","volume":"13","author":"Maroun","year":"1990","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.taap.2009.12.015","article-title":"Impact of biomarker development on drug safety assessment","volume":"243","author":"Marrer","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2016.10.001_bib0365","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.freeradbiomed.2008.10.023","article-title":"Cisplatin combined with zidovudine enhances cytoxicity and oxidative stress in human head and neck cancer cells via a thiol- dependent mechanism","volume":"46","author":"Mattson","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2016.10.001_bib0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tox.2016.10.001_bib0375","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7555\/JBR.28.20140037","article-title":"GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats","volume":"29","author":"Meng","year":"2015","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0380","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0300-483X(87)90145-4","article-title":"Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys","volume":"44","author":"Miura","year":"1987","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.10.001_bib0385","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2016.10.001_bib0390","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","article-title":"High incidence of thromboembolic events in atients treated with cisplatin-based chemotherapy: a large retrospective analysis","volume":"29","author":"Moore","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12291-010-0018-x","article-title":"Antioxidant effect of carnosine pretreatment on cisplatin-induced renal oxidative stress in rats","volume":"25","author":"Nakhaee","year":"2010","journal-title":"Indian J. Clin. Biochem."},{"issue":"78","key":"10.1016\/j.tox.2016.10.001_bib0400","first-page":"84","article-title":"Targeting superoxide dismutase to renal proximal tubule cells inhibits mitochondrial injury and renal dysfunction induced by cisplatin","volume":"387","author":"Nishikawa","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tox.2016.10.001_bib0405","first-page":"151","article-title":"Recurrent complete atrioventricular block during cisplatin infusion: a case report","volume":"2","author":"Ozcan","year":"2011","journal-title":"J. Clin. Exp. Cardiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0410","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2016.10.001_bib0415","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1152\/ajprenal.90545.2008","article-title":"The copper transporter Ctrl contributes to cisplatin uptake by renal tubular cells during cisplatin-induced nephrotoxicity","volume":"296","author":"Pabla","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0420","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"22","author":"Pai","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2016.10.001_bib0425","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0959-8049(03)00067-4","article-title":"\u03b3-Glutamyl transpeptidase catalyses the extracelular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney","volume":"39","author":"Paolicchi","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0430","first-page":"100","article-title":"Effects of furosemide- and mannitol-induced diuresis on the nephrotoxicity and physiologic disposition of cis-dichlorodiamminoplatinum in rats","volume":"19","author":"Pera","year":"1978","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0435","first-page":"1269","article-title":"Effects of mannitol or furosemide diuresis on nephrotoxicity and physiological disposition of cis-dicholorodiammineplatinum-(II) in rats","volume":"39","author":"Pera","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2016.10.001_bib0440","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1523-1755.2002.kid553.x","article-title":"Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure","volume":"62","author":"Portilla","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2016.10.001_bib0445","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4103\/0971-5851.125262","article-title":"Cisplatin induced paroxysmal supraventricular tachycardia","volume":"34","author":"Raja","year":"2013","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"10.1016\/j.tox.2016.10.001_bib0450","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-\u2191mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2016.10.001_bib0455","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1152\/ajprenal.00401.2004","article-title":"P38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice","volume":"289","author":"Ramesh","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0460","first-page":"812","article-title":"Endotoxin and cisplatin synergistically stimulate TNF-\u03b1 production by renal epithelial cells","volume":"292","author":"Ramesh","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0465","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00685715","article-title":"Cisplatin-induced reduction in renal functional reserve uncovered by unilateral nephrectomy: an experimental study in the pig","volume":"27","author":"Robbins","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2016.10.001_bib0470","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.tox.2016.10.001_bib0475","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.tox.2016.10.001_bib0480","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2015.11.028","article-title":"The effects of N-acetylcysteine on cisplatin-induced changes of cardiodynamic parameters within coronary autoregulation range in isolated rat hearts","volume":"242","author":"Rosic","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2016.10.001_bib0485","doi-asserted-by":"crossref","first-page":"555","DOI":"10.14694\/EdBook_AM.2012.32.40","article-title":"Recent advances in cardiotoxicity of anticancer therapies","volume":"32","author":"Ryberg","year":"2012","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.tox.2016.10.001_bib0490","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/10408444.2011.602662","article-title":"An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity","volume":"41","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2016.10.001_bib0495","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI200422353","article-title":"Acute renal failure: definitions, diagnosis, pathogenesis, and therapy","volume":"114","author":"Schrier","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2016.10.001_bib0500","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0272-0590(89)90026-2","article-title":"Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes","volume":"12","author":"Scott","year":"1989","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2016.10.001_bib0505","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self- defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Shen","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tox.2016.10.001_bib0510","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1152\/ajprenal.2000.278.5.F726","article-title":"Heme oxygenase- 1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis","volume":"5","author":"Shiraishi","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0515","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/bjc.1998.276","article-title":"Cisplatin dose rate as a risk factor for nephroxicity in children","volume":"77","author":"Skinner","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0520","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.toxlet.2012.12.015","article-title":"In vitro<\/it> evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells","volume":"217","author":"Sohn","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2016.10.001_bib0525","first-page":"629","article-title":"Coordination complexes of platinum as antitumor agents","volume":"59","author":"Speer","year":"1975","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.tox.2016.10.001_bib0530","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/clpt.2013.145","article-title":"Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence of antitumor efficacy and systemic clearance","volume":"94","author":"Sprowl","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.10.001_bib0535","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15407\/fz59.01.003","article-title":"Hydrogen sulfide inhibits Ca(2+)-induced mitochondrial permeability transition pore opening in spontaneously hypertensive rats","volume":"59","author":"Strutynska","year":"2013","journal-title":"Fiziol. Zh."},{"key":"10.1016\/j.tox.2016.10.001_bib0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08860220701742070","article-title":"Protective effects of vitamin C on cisplatin- induced renal damage: a light and electron microscopic study","volume":"30","author":"Tarladacalisir","year":"2016","journal-title":"Ren. Fail."},{"issue":"107","key":"10.1016\/j.tox.2016.10.001_bib0545","article-title":"Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats","volume":"9","author":"Tikoo","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0550","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2008.08.004","article-title":"Role of glutathione-S- transferase Pi in cisplatin-induced nephrotoxicity","volume":"63","author":"Townsend","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2016.10.001_bib0555","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6602772","article-title":"Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats","volume":"93","author":"Uchino","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0560","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/bjc.2014.37","article-title":"Cardiovascular sequelae in long-term survivors of young people\u2019s cancer: a linked cohort study","volume":"110","author":"van Laar","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0565","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01926230490508821","article-title":"Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology","volume":"32","author":"Vickers","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.10.001_bib0570","doi-asserted-by":"crossref","first-page":"307320","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tox.2016.10.001_bib0575","first-page":"2974","article-title":"Mechanism of cisplatin nephrotoxicity","volume":"42","author":"Weiner","year":"1983","journal-title":"Fed. Proc."},{"key":"10.1016\/j.tox.2016.10.001_bib0580","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tiv.2014.10.006","article-title":"Mechanisms of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, metabolomics and biokinetics","volume":"30","author":"Wilmes","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2016.10.001_bib0585","first-page":"F490","article-title":"Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat","volume":"90","author":"Winston","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0590","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cbi.2004.03.001","article-title":"Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitors STI571","volume":"147","author":"Wozniak","year":"2004","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2016.10.001_bib0595","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.tox.2016.10.001_bib0600","article-title":"The prevalence of silent arrhythmia in patients receiving cisplatin-based chemotherapy","volume":"38","author":"Yavas","year":"2008","journal-title":"Turk. J. Cancer"},{"key":"10.1016\/j.tox.2016.10.001_bib0605","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tox.2016.10.001_bib0610","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1681\/ASN.2006080896","article-title":"Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice","volume":"18","author":"Yin","year":"2007","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16302360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16302360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:33:33Z","timestamp":1759534413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16302360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":122,"alternative-id":["S0300483X16302360"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.10.001","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}